A systematic review and meta-analysis in Scientific Reports finds no significant difference between paracetamol and ibuprofen in treating episodic tension-type headaches, suggesting both as viable options for pain relief.
Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial Of AWKN-P001 | Psychedelic Invest
AWAKN-P001 Is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for The Treatment of Severe Alcohol Use Disorder Awakn Life Sciences Corp. (NEO: